# Sastasundar Ventures share price (Sastasundar Ventures Ltd, NSE: SASTASUNDR)

> Sastasundar Ventures share price: ₹274.85 at the NSE close on 27 March 2026, the latest close in our records; up 13.4% in the year to that date. Sastasundar Ventures (NSE: SASTASUNDR) is worth ₹874 crore, trades at a P/E of 33.7 and has closed between ₹252.95 and ₹328.35 over the past 52 weeks. > Sastasundar Ventures Ltd's share price has risen faster than its earnings: +13.4% in a year, against −1,127.2% for earnings per share. SASTASUNDR · Pharmacy Distribution · data as of 27 March 2026. Page: https://www.sectoralpha.in/stocks/sastasundar-ventures-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹274.85 (+13.4% in a year)
- P/E: 33.7× (higher than 91% of the last 1 year)
- Revenue (Dec 2025): ₹346 Cr (+22.9% on a year ago)
- Profit (Dec 2025): ₹0.4 Cr
- Operating margin: −3.0% (+5.4 points on a year ago)
- ROCE: −1%, FY25
- ROIC: −5.0%, against a 12.0% cost of capital: −17.0 points
- Profit that came in as cash: −20%, last 2 years

The main question: profits are rising, but only −20% of the last 2 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Sastasundar Ventures share price? Sastasundar Ventures Ltd's share price was ₹274.85 at the close on 27 March 2026. It has been falling for 2 weeks. That is 6.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹253 and ₹328, and at that close it sat 29% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 3 weeks in a row. Over the last 10 years the share price moved +343% while the NIFTY 500 moved +236%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Sastasundar Ventures this quarter? 4 points on a year earlier and highest quarterly revenue in 8 quarters. 1. Foreign funds (FIIs) raised their stake for 3 quarters in a row From 1.6% to 2.3% of the company by the December 2025 quarter. 2. Operating margin up 5.4 points on a year earlier -3% in the December 2025 quarter, from -8.4%. 3. Highest quarterly revenue in 8 quarters Revenue of ₹346 crore in the December 2025 quarter is the highest of the last 8 quarters. ## What are Sastasundar Ventures' latest quarterly results? For October to December 2025 (the quarter ended 31 December 2025), Sastasundar Ventures reported revenue of ₹346 crore, up 22.9% from ₹281 crore a year earlier, and a profit of ₹0.37 crore, against a loss of ₹37.8 crore a year earlier. ### Sastasundar Ventures results: October to December 2025 against a year earlier

| Measure | October to December 2025 | October to December 2024 | Change |
| --- | --- | --- | --- |
| Revenue | ₹346 crore | ₹281 crore | +22.9% |
| Profit | ₹0.37 crore | loss of ₹37.8 crore | n/a |
| Earnings per share | ₹0.36 | ₹−8.47 | n/a |
| Operating margin | −3.0% | −8.4% | +5.4 points |

The next results, for January to March 2026, are due by 30 May 2026: listed companies must publish quarterly results within 60 days of the quarter's end (the January to March quarter comes with the full-year accounts). (From the company's reported quarterly results (quarter ended 31 December 2025). Revenue and profit in ₹ crore.)

## What is the Sastasundar Ventures share price history? Sastasundar Ventures closed at ₹274.85 on 27 March 2026, up 13.4% from ₹242.42 a year earlier (28 March 2025) and up 133.9% over five years. Its highest weekly close since March 2016 was ₹560.90 on 7 January 2022. ### Sastasundar Ventures share price: then and now

| When | Close | Change to 27 Mar 2026 |
| --- | --- | --- |
| 1 week ago · 20 Mar 2026 | ₹287.85 | −4.5% |
| 1 month ago · 27 Feb 2026 | ₹283.25 | −3.0% |
| 6 months ago · 26 Sep 2025 | ₹313.20 | −12.2% |
| 1 year ago · 28 Mar 2025 | ₹242.42 | +13.4% |
| 3 years ago · 24 Mar 2023 | ₹230.10 | +19.4% |
| 5 years ago · 26 Mar 2021 | ₹117.50 | +133.9% |
| 10 years ago · 23 Mar 2016 | ₹62.80 | +337.7% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹62.05 | +342.9% |
| Highest weekly close since March 2016 · 7 Jan 2022 | ₹560.90 | −51.0% |
| Lowest weekly close since March 2016 · 18 Nov 2016 | ₹45.55 | +503.4% |
| 52-week high (weekly close) · 28 Nov 2025 | ₹328.35 | −16.3% |
| 52-week low (weekly close) · 2 May 2025 | ₹252.95 | +8.7% |

Weekly closing prices. Each change is the move from that price to the 27 Mar 2026 close. A day's intraday high or low can go beyond these weekly closes. (525 weekly closes from 11 March 2016 to 27 March 2026.)

## What is the latest news on Sastasundar Ventures? 27 Mar 2026: Sastasundar Ventures closed at ₹274.85, down 4.5% on the week and down 3.0% on the month. Results for October to December 2025: Revenue up 22.9% on a year earlier. ## What dividend does Sastasundar Ventures pay? Sastasundar Ventures has paid no dividend on the NSE since 1 April 2021, the start of the period we checked. No. Sastasundar Ventures Ltd paid out 0% of its profit as dividends in each of its last 12 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is Sastasundar Ventures on? Sastasundar Ventures is on one of our India lists: Pharma stocks. [Pharma stocks Market value (₹ crore): 874](https://www.sectoralpha.in/sectors/pharma-stocks-india)

## Is Sastasundar Ventures profitable? Sastasundar Ventures Ltd earned ₹0.4 Cr of net profit in the Dec 2025 quarter. The full FY25 year was a loss of ₹134 Cr. That is 0.1% of the quarter's revenue. The same quarter a year earlier lost ₹37.8 Cr. 7 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was −₹134 Cr (−2,333.3% on the year before). ## How much revenue does Sastasundar Ventures make, and is it growing? Sastasundar Ventures Ltd reported ₹346 Cr of revenue in the Dec 2025 quarter, +22.9% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 10 years it has grown 36.4% a year on average. The last full year, FY25, came in at ₹1,159 Cr. The last four reported quarters add to ₹1,231 Cr. FY25 revenue was ₹1,159 Cr, −19.1% on the year before. Recent pace: the last four quarters grew +9.2% on average, against 36.4% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +8.8%, against −5.6% a year over the last 8 quarters (accelerating). ## How much of every ₹100 of sales does Sastasundar Ventures keep? Sastasundar Ventures Ltd's operating margin was −3.0% in the Dec 2025 quarter, 5.4 percentage points higher than the same quarter a year ago. Across 12 years it has been between −31.0% and 62.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +5.4 percentage points on the year while gross margin changed +2.3 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Sastasundar Ventures' profit turning into cash? Over the last 2 years Sastasundar Ventures Ltd's operations used more cash than they brought in, so cash conversion was −20%, a gap worth watching. In FY25 its operations used ₹17.0 Cr of cash, against −₹134 Cr of profit. After ₹8.0 Cr of spending on assets, free cash was −₹25.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why −20% of profit came in as cash: the cash cycle got 19 days shorter between FY20 and FY25, so cash that used to wait in the business now arrives sooner. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: the bigger use of cash is spending on new assets, at 1.8× depreciation over three years. The next section checks what that spending is building. ## Where does Sastasundar Ventures' cash go? Sastasundar Ventures Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 22 days in FY25, down from 41 days in FY20. It spent ₹42.0 Cr on assets over the last 3 years. Customers take 3 days to pay, and stock sits for 40 days on average. At FY25 sales of ₹1,159 Cr, each day of that cycle ties up about ₹3.2 Cr, so roughly ₹70.0 Cr is tied up in the business at any time. FY25: customers took 3 days to pay and stock sat for 40 days, about 1.3 months of sales sitting as stock, for a full cycle of 22 days, shorter than FY20's 41. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 40 days. Customers pay about 3 days after that. Suppliers are paid at 21 days. Together that makes the 22-day cycle. Spending on assets: ₹42.0 Cr over the last 3 years, against ₹23.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹10.0 Cr (FY25): assets paid for that are not earning yet. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Sastasundar Ventures' P/E ratio, and how does it compare with its own history? Sastasundar Ventures Ltd's P/E is 33.7×, near the high end of its own history: higher than 91% of past readings. Its usual P/E (the middle reading) is 22.6×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −1,127.2% while the price moved +13.4%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## What growth does the Sastasundar Ventures share price assume? Worked out from its price on 13 June 2026, Sastasundar Ventures Ltd's share price assumed profit growth of about 20.9% a year. Today its P/E is 33.7×, higher than 91% of its own last 1 year. This is a one-day reading, taken on 13 June 2026. Every other number on this page, the multiple included, uses the latest price as of 27 March 2026. A higher price assumes more growth and a lower price less, so it changes whenever the price changes, and this page does not update it between measurements. ## Is the Sastasundar Ventures business getting better or worse? Sastasundar Ventures Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 9 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Sastasundar Ventures earn on its capital? Sastasundar Ventures Ltd earned a ROCE of −1% in FY25. That is up from a low of −25% in FY20. Its return on capital used (ROIC) is 17.0 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −11.6% net margin and 1.19× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −11.6% net margin × 1.19× asset turnover × 1.45× leverage (assets divided by equity) ≈ −20.0% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −5.0% − 12.0% = −17.0 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Sastasundar Ventures have too much debt? Sastasundar Ventures Ltd had ₹1.0 Cr of borrowings against ₹670 Cr of equity in FY25, so its debt is 0.00× its equity. Over 5 years borrowings went from ₹8.0 Cr to ₹1.0 Cr. Over the last 3 of those years it spent ₹42.0 Cr on assets. The spending on assets is being paid for from cash, not new debt. ## What is the Sastasundar Ventures shareholding pattern? Foreign institutions raised their stake in Sastasundar Ventures Ltd by 1.8 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 2.3% of the company. Domestic institutions moved +1.2 points over the same period, to 2.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: +1.8 points over 8 quarters, to 2.3%; Domestic institutions: +1.2 points over 8 quarters, to 2.1%; Promoters: +0.8 points over 8 quarters, to 74.7%. Why the owners changed: foreign institutions drove it (+1.8 points), together with domestic institutions (+1.2 points). They raised their stake step by step. ## How far is Sastasundar Ventures from balance-sheet trouble? For Sastasundar Ventures Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Sastasundar Ventures rank in its industry? 39.2 out of 100, rank 5 of 5 in Pharmacy Distribution, with 36% of the evidence available. It is provisional, so it is ranked below companies with full evidence. Sastasundar Ventures Ltd scores 39.2 out of 100 against the 5 companies it is compared with in Pharmacy Distribution, ranking 5. Some evidence is missing, so the score is pulled toward the middle on purpose. The three scored parts add up to the total exactly: 23.1 + 6.8 + 9.3 = 39.2 (no relative-strength reading this week; its 20 points are shared across the other three). This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Sastasundar Ventures compared with? Sastasundar Ventures ranks 5 of 5 Pharmacy Distribution companies on the 4-Factor Sector Score, with 39.2 out of 100. 1. [Entero Healthcare Solutions Ltd](https://www.sectoralpha.in/stocks/entero-healthcare-solutions-ltd) ENTERO · breaking out · Most evidence points up · 68% evidence 68.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Revenue 31.9% · Profit 44.8% · Operating margin change 1.4 points · 83% evidence Capital efficiency 14.1/25 · ROCE 10.5% · Operating margin 5% · 76% evidence Valuation 10.0/20 · P/E 53.2× · PEG n/a · 0% evidence Relative strength 20.0/20 · Lead over its industry 27% · Lead over NIFTY 500 30.4% · 1 year 42.5% · 100% evidence · 11 of 12 weeks ahead Exact sum: 24.8 + 14.1 + 10 + 20 = 68.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Zota Health Care Ltd](https://www.sectoralpha.in/stocks/zota-health-care-ltd) ZOTA · turning · Too little evidence to rank firmly · 56% evidence 45.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.6/35 · Revenue 68.9% · Profit -80% · Operating margin change -3.4 points · 74% evidence Capital efficiency 1.3/25 · ROCE -8.5% · Operating margin 1.5% · 100% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 6.3% · 1 year -12.1% · 25% evidence · 3 of 12 weeks ahead Exact sum: 21.6 + 1.3 + 10 + 12.5 = 45.4 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 3. [Health X Platform Ltd](https://www.sectoralpha.in/stocks/health-x-platform-ltd) HEALTHX · quiet · Too little evidence to rank firmly · 53% evidence 45.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.5/35 · Revenue 28.9% · Profit 82.5% · Operating margin change -3.9 points · 83% evidence Capital efficiency 8.6/25 · ROCE 0% · Operating margin -1.9% · 76% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 8.3/20 · Lead over its industry n/a · Lead over NIFTY 500 -3.4% · 1 year n/a · 25% evidence · 1 of 12 weeks ahead Exact sum: 18.5 + 8.6 + 10 + 8.3 = 45.4 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 4. [Medplus Health Services Ltd](https://www.sectoralpha.in/stocks/medplus-health-services-ltd) MEDPLUS · basing · Evidence leans down · 90% evidence 44.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.2/35 · Revenue 20.6% · Profit 8.2% · Operating margin change -1 points · 100% evidence Capital efficiency 18.1/25 · ROCE 12.6% · Operating margin 8% · 100% evidence Valuation 13.5/20 · P/E 33× · PEG 1 · 50% evidence Relative strength 0.0/20 · Lead over its industry -25% · Lead over NIFTY 500 -22.7% · 1 year -24% · 100% evidence · 0 of 12 weeks ahead Exact sum: 13.2 + 18.1 + 13.5 + 0 = 44.8 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 5. Sastasundar Ventures Ltd this page SASTASUNDR · Too little evidence to rank firmly · 36% evidence 39.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.1/43.75 · Revenue 8.8% · Profit 100% · Operating margin change 5.4 points · 33% evidence Capital efficiency 6.8/31.25 · ROCE -1.3% · Operating margin -3% · 71% evidence Valuation 9.3/25 · P/E 33.7× · PEG n/a · 35% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 23.1 + 6.8 + 9.3 = 39.2 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Pharmacy Distribution](https://www.sectoralpha.in/sectors/pharmacy-distribution), all 5 compared on one page. ## Which companies are close to Sastasundar Ventures in size? Sastasundar Ventures is the 5th largest of 5 Pharmacy Distribution companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Medplus Health Services, Entero Healthcare Solutions, Zota Health Care and Health X Platform. It is the smallest. ### Pharmacy Distribution companies close in size

1. [Medplus Health Services Ltd](https://www.sectoralpha.in/stocks/medplus-health-services-ltd) ₹6,968 crore
2. [Entero Healthcare Solutions Ltd](https://www.sectoralpha.in/stocks/entero-healthcare-solutions-ltd) ₹6,863 crore
3. [Zota Health Care Ltd](https://www.sectoralpha.in/stocks/zota-health-care-ltd) ₹4,602 crore
4. [Health X Platform Ltd](https://www.sectoralpha.in/stocks/health-x-platform-ltd) ₹921 crore
5. Sastasundar Ventures Ltd ₹874 crore

[All 5 Pharmacy Distribution companies, largest first](https://www.sectoralpha.in/sectors/pharmacy-distribution#all-companies)

### Companies close in size in other industries

1. [Unihealth Hospitals Ltd](https://www.sectoralpha.in/stocks/unihealth-hospitals-ltd) ₹875 crore · Hospitals/Medical Services
2. [Bizotic Commercial Ltd](https://www.sectoralpha.in/stocks/bizotic-commercial-ltd) ₹874 crore · Trading
3. Sastasundar Ventures Ltd ₹874 crore
4. [Bombay Super Hybrid Seeds Ltd](https://www.sectoralpha.in/stocks/bombay-super-hybrid-seeds-ltd) ₹873 crore · Seeds/Tissue Culture/Bio Technology
5. [Themis Medicare Ltd](https://www.sectoralpha.in/stocks/themis-medicare-ltd) ₹873 crore · Pharma - API

## What else do people ask about Sastasundar Ventures? ### What were Sastasundar Ventures's latest quarterly results? Sastasundar Ventures Ltd reported revenue of ₹346 Cr and net profit of ₹0.4 Cr for the Dec 2025 quarter. Earnings per share were ₹0.36. The operating margin was −3.0%, 5.4 percentage points higher than a year earlier (as of 27 March 2026). ### What is Sastasundar Ventures's market cap? Sastasundar Ventures Ltd's market capitalisation is ₹874 Cr at a share price of ₹274.85. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 27 March 2026). ### How is Sastasundar Ventures performing? Sastasundar Ventures Ltd's share price has been falling for 2 weeks. Over the past 13 weeks it has done better than the NIFTY 500, for 3 weeks running. This describes what the data did, not a rating (as of 27 March 2026). ### Will Sastasundar Ventures's share price go up? This page does not forecast Sastasundar Ventures Ltd's share price. What it shows instead: the share price is ₹274.85, and it has been falling for 2 weeks. Its P/E of 33.7× is higher than 91% of its own last 2 years (as of 27 March 2026). ### Who owns Sastasundar Ventures? Promoters own 74.7% of Sastasundar Ventures Ltd, foreign institutions 2.3%, domestic institutions 2.1% and the public 21.0% (latest quarter). The biggest change over the last two years: Foreign institutions raised their stake by 1.8 percentage points over 8 quarters (as of 27 March 2026). ### Where is Sastasundar Ventures in its business cycle? Sastasundar Ventures Ltd's FY25 operating margin was −2.0%, against a 12-year range of −31.0% to 62.0%: the middle of its own range, neither a peak nor a low. The latest quarter was −3.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 27 March 2026). ### What could break the Sastasundar Ventures story? The main question: profits are rising, but only −20% of the last 2 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 27 March 2026). ### Is Sastasundar Ventures a stock worth studying right now? What the numbers show: Sastasundar Ventures Ltd's share price has risen faster than its earnings: +13.4% in a year, against −1,127.2% for earnings per share. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 27 March 2026). ## Lists

- Pharma stocks: https://www.sectoralpha.in/sectors/pharma-stocks-india

This is research, not advice. We’re not SEBI-registered.